Dupont Capital Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Dupont Capital Management’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	–	–	1727
2022 Q3	$0	Hold	1	–	–	﹤0.01%	1821
2022 Q2	$0	Hold	1	–	–	﹤0.01%	1891
2022 Q1	$0	Hold	1	–	–	﹤0.01%	1913
2021 Q4	$0	Hold	1	–	–	﹤0.01%	1970
2021 Q3	$0	Hold	1	–	–	﹤0.01%	1933
2021 Q2	$0	Hold	1	–	–	﹤0.01%	2003
2021 Q1	$0	Sell	1 -24,999	-100%	-$266K	﹤0.01%	1717
2020 Q4	$260K	Buy	+25,000	New	+$261K	0.01%	1084

Dupont Capital Management's FLACU Position: Q4 2022 in Review

Dupont Capital Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 1 share.

Dupont Capital Management first reported a position in FLACU in Q4 2020 and held it in 8 quarters. The position peaked at $260K in Q4 2020. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

Dupont Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
Dupont Capital Management sold 1 Frazier Lifesciences Acquisition Corporation Unit share in Q4 2022.
Dupont Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
Dupont Capital Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $260K in Q4 2020.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.